S. Schmitz

458 total citations
34 papers, 344 citations indexed

About

S. Schmitz is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, S. Schmitz has authored 34 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Economics and Econometrics. Recurrent topics in S. Schmitz's work include Clinical practice guidelines implementation (6 papers), Erythrocyte Function and Pathophysiology (4 papers) and Economic and Financial Impacts of Cancer (4 papers). S. Schmitz is often cited by papers focused on Clinical practice guidelines implementation (6 papers), Erythrocyte Function and Pathophysiology (4 papers) and Economic and Financial Impacts of Cancer (4 papers). S. Schmitz collaborates with scholars based in Germany, United Kingdom and Netherlands. S. Schmitz's co-authors include Markus Loeffler, H. E. Wichmann, Volker Diehl, Brittani Bungart, Hans Tesch, W Nijhof, Christoph Engel, J. B. Jones, D. Voliotis and Frank Krummenauer and has published in prestigious journals such as Annals of Oncology, Molecular Biology and Evolution and Pflügers Archiv - European Journal of Physiology.

In The Last Decade

S. Schmitz

29 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Schmitz Germany 11 114 88 83 78 48 34 344
Taro Okayama Japan 11 114 1.0× 88 1.0× 89 1.1× 169 2.2× 59 1.2× 24 490
Maoquan Qin China 10 90 0.8× 137 1.6× 46 0.6× 65 0.8× 17 0.4× 45 341
Ahmad Malluh United States 10 73 0.6× 131 1.5× 96 1.2× 44 0.6× 28 0.6× 11 341
Muss Hb United States 10 105 0.9× 116 1.3× 28 0.3× 74 0.9× 62 1.3× 18 454
Yanli Xu China 12 65 0.6× 94 1.1× 34 0.4× 31 0.4× 43 0.9× 38 325
Toshiaki Ishida Japan 11 112 1.0× 63 0.7× 41 0.5× 27 0.3× 78 1.6× 51 439
Ci Pan China 14 107 0.9× 96 1.1× 21 0.3× 40 0.5× 35 0.7× 37 405
A. Ferster Belgium 9 76 0.7× 232 2.6× 63 0.8× 25 0.3× 17 0.4× 11 370
Ian Thornley Canada 11 39 0.3× 182 2.1× 36 0.4× 85 1.1× 24 0.5× 12 330
Motoko Nishimura Japan 13 36 0.3× 172 2.0× 82 1.0× 71 0.9× 27 0.6× 39 560

Countries citing papers authored by S. Schmitz

Since Specialization
Citations

This map shows the geographic impact of S. Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Schmitz more than expected).

Fields of papers citing papers by S. Schmitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Schmitz. The network helps show where S. Schmitz may publish in the future.

Co-authorship network of co-authors of S. Schmitz

This figure shows the co-authorship network connecting the top 25 collaborators of S. Schmitz. A scholar is included among the top collaborators of S. Schmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Schmitz. S. Schmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schuh, Günther, et al.. (2021). Management Framework for the Highly Iterative and Integrated Product and Production Process Development (HIP3D). 2021 IEEE International Conference on Industrial Engineering and Engineering Management (IEEM). 750–754.
2.
Schuh, Günther, et al.. (2015). Produktionsdaten als Enabler für Industrie 4.0/Production data as enabler for Industrie 4.0. wt Werkstattstechnik online. 105(4). 200–203. 3 indexed citations
3.
Zimmermann, Alexander, et al.. (2014). Machbarkeitsanalyse von Qualitätsindikatoren zur Messung der Qualität der ambulanten onkologischen Versorgung mit Daten aus Patientendokumentationen. Gesundheitsökonomie & Qualitätsmanagement. 20(1). 36–42. 3 indexed citations
4.
Ernstmann, Nicole, Sophie E. Groß, Lena Ansmann, et al.. (2014). Fluktuation bei nicht-ärztlichem Personal in onkologischen Schwerpunktpraxen: Sozialkapitalaufbau als Lösungsansatz?. Das Gesundheitswesen. 77(11). 875–880. 1 indexed citations
5.
Schmitz, S., et al.. (2012). Qualitätssicherung und Qualitätsindikatoren. Der Onkologe. 18(2). 134–141. 1 indexed citations
6.
Zautner, Andreas E., et al.. (2008). Subcutaneous Fistulae in a Patient with Femoral Hypoplasia due to Actinomyces europaeus and Actinomyces turicensis. Infection. 37(3). 289–291. 9 indexed citations
7.
Schmitz, S., et al.. (2008). Qualitätsmonitoring mit Indikatoren. Der Onkologe. 14(12). 1260–1267. 1 indexed citations
8.
Beckmann, Matthias W., Peter Albers, G. Ehninger, et al.. (2008). Onkologie. 3-Stufen-Modell optimiert Behandlung unter Kostendeckung. Wie die künftigen Strukturen der onkologischen Versorgung in Deutschland aussehen sollten. Geburtshilfe und Frauenheilkunde. 68(6). 658–661. 11 indexed citations
10.
Schmitz, S., et al.. (2005). Qualitätssicherung in der ambulanten onkologischen Krankenversorgung. Der Onkologe. 11(12). 1278–1285. 1 indexed citations
11.
Schmitz, S.. (2003). Molecular Evolutionary Convergence of the Flight Muscle Protein Arthrin in Diptera and Hemiptera. Molecular Biology and Evolution. 20(12). 2019–2003. 7 indexed citations
12.
Breil, Pascal, Frank Krummenauer, S. Schmitz, & Norbert Pfeiffer. (2002). Verhältnis zwischen retrobulbären Blutflussgeschwindigkeiten und glaukomatösem Schaden. Der Ophthalmologe. 99(8). 613–616. 10 indexed citations
13.
Engel, Christoph, Markus Loeffler, S. Schmitz, Hans Tesch, & Volker Diehl. (2000). Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. Annals of Oncology. 11(9). 1105–1114. 32 indexed citations
14.
Schmitz, S., et al.. (1994). Continuous 5-Fluorouracil and Leucovorin as a Second-Line Therapy for Advanced Gastric Carcinoma. Oncology. 51(6). 502–506. 8 indexed citations
15.
Schmitz, S., Stefan Scheding, D. Voliotis, et al.. (1994). Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood. Annals of Hematology. 69(3). 135–138. 11 indexed citations
16.
Schmitz, S., et al.. (1993). Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis.. PubMed. 21(6). 755–60. 55 indexed citations
17.
Schmitz, S., et al.. (1990). Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis. Cell Proliferation. 23(5). 425–442. 32 indexed citations
18.
Loeffler, Markus, et al.. (1989). Hemopoiesis during thiamphenicol treatment. I. Stimulation of stem cells during eradication of intermediate cell stages.. PubMed. 17(9). 957–61. 6 indexed citations
19.
Loeffler, Markus, et al.. (1989). Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.. PubMed. 17(9). 962–7. 7 indexed citations
20.
Schmitz, S., et al.. (1965). Chronotrope Wirkung von Calcium und Magnesium am isolierten Hundeherzen. Pflügers Archiv - European Journal of Physiology. 284(4). 316–326. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026